Spots Global Cancer Trial Database for Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies
Official Title: A Phase IA/II, Multi-center, Open-label Study of HCD122 Administered Intravenously Once Weekly for Four Weeks in Adult Patients With Advanced Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies (CHIR-12.12-LYM-01)
Study ID: NCT00670592
Interventions
Study Description
Brief Summary: This study is to evaluate the highest tolerated dose, safety and activity of HCD122 in adults with non-Hodgkin's or Hodgkin's lymphoma who have received at least two prior therapies.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Northwestern University, Chicago, Illinois, United States
St. Francis Cancer Research Foundation Dept.ofSt.FrancisCancerRes.(2), Beech Grove, Indiana, United States
Dana Farber Cancer Institute SC-5, Boston, Massachusetts, United States
Wake Forest University Baptist Medical Center Dept. of Industry Research (2), Winston-Salem, North Carolina, United States
University of Texas/MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(3), Houston, Texas, United States
Novartis Investigative Site, Parkville, Victoria, Australia
Novartis Investigative Site, Prahran, Victoria, Australia
Novartis Investigative Site, Gent, , Belgium
Novartis Investigative Site, Godinne, , Belgium
Novartis Investigative Site, Leuven, , Belgium
Novartis Investigative Site, Toronto, Ontario, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Creteil, , France
Novartis Investigative Site, Le Mans Cedex, , France
Novartis Investigative Site, Lille Cedex, , France
Novartis Investigative Site, Montpellier cedex 5, , France
Novartis Investigative Site, Paris, , France
Novartis Investigative Site, Pierre-Benite Cédex, , France
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Köln, , Germany
Novartis Investigative Site, Hong Kong, , Hong Kong
Novartis Investigative Site, Bologna, BO, Italy
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Pisa, PI, Italy
Novartis Investigative Site, Seoul, Korea, Korea, Republic of
Novartis Investigative Site, Singapore, , Singapore
Novartis Investigative Site, Leicester, , United Kingdom
Novartis Investigative Site, London, , United Kingdom
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Name: Novartis Pharmaceuticlas
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
